Kellerhals Carrard advised Maestrani Schweizer Schokoladen on taking over the production infrastructure for chocolate-coated marshmallow treats (Schokoladenküsse) from Chocolat Ammann. The context Pursuant to the acquisition, the Swiss family-owned company further expands its brand
Tags :sx1
Altenburger advised diamond manufacturer Rosy Blue on its acquisition of a majority stake in Swiss watches and jewellery specialist Diatheke. The context Headquartered in Anversa, buyer Rosy Blue is globally active in the trading of
Altenburger advised TV-streaming provider Zattoo on its acquisition of Green Streams. The parties Headquartered in Berlin, selling part Green Streams serves telecommunications and pay-TV providers with a media integration platform, allowing operators to merge existing
Altenburger advised SwissComply Group in connection with the acquisition of Lexpert Partners. The context Headquartered in Zurich, SwissComply Group specialises across compliance, risk management, and legal services. In connection with the deal, the company completed
Walder Wyss advised Zurich-based Veraxa Biotech on its merger with Voyager Acquisition Corp, a Cayman Islands publicly traded Special Purpose Acquisition Company (SPAC), which was instead represented by Bratschi. The context The companies signed an
MME advised medtech buy-and-build platform Healthcare Holding Schweiz on its acquisition of CDP Swiss and Aesthetic Bedarf. The company Headquartered in Baar, Zug, Healthcare Holding Schweiz focuses on strategic acquisitions, partnerships, and organic expansion initiatives
Homburger advised 21Shares on the issuance and listing of its Dogecoin-linked Exchange Traded Product (DOGE) on the SIX Swiss Exchange. The context The issuance in question is linked to and fully physically collateralized by Dogecoin
Homburger advised New Zealand Local Government Funding Agency (LGFA) in connection with its debut issuance under its EMTN Programme, marking the the agency’s first issuance in CHF. UBS Investment Bank and BNP Paribas (Suisse) &
Walder Wyss advised Swiss Life on a EUR 500 million senior bond placement. In connection with the operation, Homburger represented BNP Paribas, J.P. Morgan, Natixis and UBS Europe, acting as joint lead managers. Moreover, UBS
Swiss biotechnology company Araris Biotech completed its sale to Taiho Pharmaceutical. In connection with the deal BGPartner advised Araris on all Swiss legal matters, while Baker McKenzie represented the company with regard to all Swiss
